Politics
Nebraska Officials Advance Medical Marijuana Rules Without Changes To Testing And Fees Provisions
Medical cannabis cultivation businesses has requested amendments on those issues.
By Zach Wendling, Nebraska Examiner
Proposed amendments to Nebraska’s regulations for medical cannabis establishments will proceed as-is to Attorney General Mike Hilgers (R) for legal review despite all four of the state’s licensed cultivators urging changes around testing availability and fees.
The Nebraska Medical Cannabis Commission voted unanimously Monday to forward the amendments to the Nebraska AG’s Office for constitutional review. The state’s licensed cultivators sent a joint letter in October asking the commission to consider changes.
Dustin Krajewski of Meadowlark Medicinals LLC, former state Sen. Kent Rogert of KRL Med LLC, Pat Thomas of MahāMotā Cultivation Co. and Robert Wagner of Midwest Cultivators Group signed the letter.
If Hilgers signs off on the constitutionality of the amendments, the proposal will head to Gov. Jim Pillen (R) for approval. If he signs, the amendments would take effect five days later.
Power of the commission
The Legislature did not authorize the commission to assess fees until April, and the commission had already been working to finalize a prior set of regulations. The commission is refusing to grant more licenses until it can assess fees for future licenses.
A MahāMotā representative said in October that the company was on track to harvest this year but saw no path to how testing facilities could legally receive, possess or test their plant.
“We request an update to the current proposed regulations that provide clarification of the licensing or authorization process, who may transport samples to a laboratory, how transportation and manifest requirements apply to those transfers and whether out-of-state laboratories may be used,” the cultivators said in their letter.
Under the voter-approved laws in 2024, regulatory power over “registered cannabis establishments” for the possession, manufacture, distribution, delivery and dispensing of medical cannabis is “vested exclusively” in the voter-created commission.
A registered cannabis establishment is defined as a private entity licensed to possess, manufacture, distribute, deliver or dispense cannabis for medical purposes.
Unless the Legislature changes that definition to include testing, the commission has no authority to grant in-state private facilities legal possession of marijuana.
Proposed regulatory amendments
Interim Commission Chair Lorelle Mueting had told the MahāMotā representative last month that the company had assured the commission that cannabis could be safely stored for up to two years. The commission last week clarified that it wasn’t estimating a two-year timeline before testing would be available.
At the same time, the commission offered no new estimate for when testing will be available.
The latest commission amendments offer a few distinct changes from current regulations, the largest of which is proposed fees for applicants—a $5,000 application fee, annual license and renewal fees based on type (between $10,000 and $28,500), a $1,500 relocation fee and a $13,000 fee for participation in the state’s seed-to-sale inventory tracking system. Dispensaries would also need to pay a $250 fee to license a new product, plus a $100 renewal fee.
Currently, there are no fees under the program. Sales taxes are currently prohibited by law.
The latest amendments would also merge transporter licenses with product manufacturers, so transportation would be an optional certification.
Other notable changes:
- Removing a label that would list medical cannabis as a “Schedule I” controlled substance. In May, the federal government downgraded state-licensed medical cannabis from a Schedule I drug to a Schedule III drug.
- Allowing disenrollment of healthcare practitioners who voluntarily choose to participate in the program if the practitioner fails to maintain a medical license in good standing.
- Requiring healthcare practitioners to attest when an in-person appointment occurs before they issue a recommendation for medical cannabis.
- Attesting whether a provider knows whether a patient is pregnant before recommending medical cannabis. If the provider in the future learns a patient is pregnant, they must alert the commission.
Current regulatory requirements
The current medical cannabis regulations call for the state to:
- Establish a “Recommending Health Care Practitioner” directory and require patients who want to access Nebraska-licensed dispensaries to go through one of the in-state providers.
- Cap cultivators at no more than 1,250 flowering plants at one time.
- Restrict purchases of medical cannabis to 5 ounces of medical cannabis in 30 days, of which no more than 5 grams can be delta-9 tetrahydrocannabinol (THC) from the same dispensary. Delta-9 THC is the part of cannabis most associated with a “high.”
- Allow no more than 12 medical cannabis dispensaries statewide, arranged by judicial district. That would mean one dispensary each in Douglas County (584,526 residents), Lancaster County (322,608 residents), Sarpy/Cass counties (217,202 residents) and Buffalo/Hall counties (112,979 residents), according to 2020 census data.
- Prohibit the sale of smoking or vaping products and edibles of any kind.
Under current state law, possession of up to 5 ounces of medical cannabis is permitted with the written recommendation of any healthcare practitioner.
When asked last week whether the commission would support legislative changes ahead of the 2027 session, which begins January 6, a commission spokesperson told the Nebraska Examiner that the commission “continues to evaluate the statutory and regulatory steps necessary to fully implement Nebraska’s medical cannabis program.”
The commission’s next meeting is scheduled for December 14.
This story was first published by Nebraska Examiner.
Photo courtesy of Chris Wallis // Side Pocket Images.

